DrugPatentWatch Database Preview
Details for Patent: 10,166,247
Try a free trial
See Plans and Pricing
Which drugs does patent 10,166,247 protect, and when does it expire?
Patent 10,166,247 protects SYMBICORT and is included in one NDA.
This patent has forty-five patent family members in twenty-seven countries.
Summary for Patent: 10,166,247
| Title: | Composition for inhalation |
| Abstract: | The invention relates to a formulation comprising formoterol and budesonide for use in the treatment of respiratory diseases. The composition further contains HFA 227, PVP and PEG, preferably PVP K25 and PEG 1000. |
| Inventor(s): | Govind; Nayna (Loughborough, GB), Marlow; Maria (Loughborough, GB) |
| Assignee: | AstraZeneca AB (Sodertalje, SE) |
| Application Number: | 15/427,425 |
|
Patent Claim Types: see list of patent claims | Use; Composition; |
Drugs Protected by US Patent 10,166,247
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Astrazeneca | SYMBICORT | budesonide; formoterol fumarate dihydrate | AEROSOL, METERED;INHALATION | 021929-001 | Jul 21, 2006 | RX | Yes | Yes | ➤ Sign Up | ➤ Sign Up | Y | USE FOR THE TREATMENT OF ASTHMA IN PATIENTS 6 YEARS OF AGE AND OLDER | ➤ Sign Up | |||
| Astrazeneca | SYMBICORT | budesonide; formoterol fumarate dihydrate | AEROSOL, METERED;INHALATION | 021929-001 | Jul 21, 2006 | RX | Yes | Yes | ➤ Sign Up | ➤ Sign Up | Y | USE FOR REDUCING EXACERBATIONS OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE | ➤ Sign Up | |||
| Astrazeneca | SYMBICORT | budesonide; formoterol fumarate dihydrate | AEROSOL, METERED;INHALATION | 021929-001 | Jul 21, 2006 | RX | Yes | Yes | ➤ Sign Up | ➤ Sign Up | Y | USE FOR MAINTENANCE TREATMENT OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE | ➤ Sign Up | |||
| Astrazeneca | SYMBICORT | budesonide; formoterol fumarate dihydrate | AEROSOL, METERED;INHALATION | 021929-002 | Jul 21, 2006 | RX | Yes | Yes | ➤ Sign Up | ➤ Sign Up | Y | USE FOR THE TREATMENT OF ASTHMA IN PATIENTS 6 YEARS OF AGE AND OLDER | ➤ Sign Up | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
Foreign Priority and PCT Information for Patent: 10,166,247
| Foriegn Application Priority Data | ||
| Foreign Country | Foreign Patent Number | Foreign Patent Date |
| Sweden | 0200312 | Feb 1, 2002 |
International Family Members for US Patent 10,166,247
| Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
|---|---|---|---|---|---|
| Austria | 423552 | ➤ Sign Up | |||
| Austria | 463241 | ➤ Sign Up | |||
| Australia | 2003206289 | ➤ Sign Up | |||
| Brazil | 0307193 | ➤ Sign Up | |||
| >Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |
